SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-232252
Filing Date
2024-10-03
Accepted
2024-10-03 16:19:54
Documents
16
Period of Report
2024-09-27
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d860501d8k.htm   iXBRL 8-K 49641
2 EX-99.1 d860501dex991.htm EX-99.1 15233
6 GRAPHIC g860501g02p04.jpg GRAPHIC 3451
7 GRAPHIC g860501g28g18.jpg GRAPHIC 10079
  Complete submission text file 0001193125-24-232252.txt   218608

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA igms-20240927.xsd EX-101.SCH 2836
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE igms-20240927_lab.xml EX-101.LAB 17979
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE igms-20240927_pre.xml EX-101.PRE 11249
18 EXTRACTED XBRL INSTANCE DOCUMENT d860501d8k_htm.xml XML 3637
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39045 | Film No.: 241351781
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)